Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Medical University of South Carolina
Cedars-Sinai Medical Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Centre hospitalier de l'Université de Montréal (CHUM)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
University Hospital, Tours
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Albert Einstein College of Medicine
Universidad Europea de Madrid
West China Hospital
Abramson Cancer Center at Penn Medicine
ModernaTX, Inc.
PETHEMA Foundation
Hôpital du Valais
Xuanwu Hospital, Beijing
Lepu Biopharma Co., Ltd.
Shanghai Chest Hospital
Hoosier Cancer Research Network
Zhejiang University
Protara Therapeutics
Shanghai Henlius Biotech
Shanghai Junshi Bioscience Co., Ltd.
Nanfang Hospital, Southern Medical University
University Health Network, Toronto
Dong-A ST Co., Ltd.
Centre Oscar Lambret
University of California, San Francisco
GlaxoSmithKline
Case Comprehensive Cancer Center
University of Iowa
National Cancer Institute (NCI)
National Cancer Institute (NCI)
D3 Bio (Wuxi) Co., Ltd